112 related articles for article (PubMed ID: 10433081)
1. Function of rat pancreatic islets exposed to interleukin-18 in vitro.
Krook H; Wallström J; Sandler S
Autoimmunity; 1999; 29(4):263-7. PubMed ID: 10433081
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-15 on suppression of rat pancreatic islets in vitro induced by proinflammatory cytokines.
Wallström J; Andersson AK; Sandler S
Immunol Lett; 2003 Aug; 88(2):141-5. PubMed ID: 12880684
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
Sandler S; Sternesjö J
Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
9. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
Sandler S; Andersson A; Hellerström C
Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
12. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap.
Rydgren T; Bengtsson D; Sandler S
Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro.
Sandler S; Buschard K; Bendtzen K
Immunol Lett; 1994 Jun; 41(1):73-7. PubMed ID: 7959906
[TBL] [Abstract][Full Text] [Related]
15. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
16. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
17. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
Eizirik DL; Welsh N; Hellerström C
J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
[TBL] [Abstract][Full Text] [Related]
18. Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets.
Sternesjö J; Bendtzen K; Sandler S
Autoimmunity; 1995; 20(3):185-90. PubMed ID: 7578879
[TBL] [Abstract][Full Text] [Related]
19. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
Bleich D; Chen S; Bursten SL; Nadler JL
Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
